Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jun 2.
Published in final edited form as: Lancet Infect Dis. 2022 Apr;22(4):451–452. doi: 10.1016/S1473-3099(22)00121-9

Endemic mycoses: geographical distribution is still a work in progress

Thuy Le 1, Alessandro C Pasqualotto 2, George R Thompson III 3
PMCID: PMC10236952  NIHMSID: NIHMS1896499  PMID: 35338870

Authors’ reply

We thank Spinello Antinori and colleagues for their interest in our Review.1 Our primary objective was to provide evidence-based guidelines for the diagnosis and treatment of endemic mycoses. A comprehensive review of the epidemiology and geographical distribution of endemic mycoses was not the main objective of our paper. We, however, acknowledge that the maps provided were not an exhaustive effort to redraw the global distribution of endemic mycoses. Neither did they include all published case reports to date. We confirm that, on the talaromycosis map, the states of Assam and Sikkim, in addition to the state of Manipur in the north-eastern region of India, were included in the endemic region. Antinori and colleagues were correct in pointing out that Australia should not be the only continent with imported cases as indicated on the map. Imported talaromycosis cases have been reported in all continents of the world, with the exception of Antarctica.2 Antinori and colleagues were also correct in pointing out, on the histoplasmosis map, that although cases are concentrated in the north and north-eastern regions of India, sporadic cases have been reported throughout India.3 Indeed, although histoplasmosis is hyper-endemic in parts of the USA and Latin America, histoplasmin skin-test surveys and sporadic autochthonous cases suggest that histoplasmosis occurs throughout much of the world.4 Until we have reliable diagnostic tests that can detect exposure to these endemic fungal pathogens, and until we have comprehensive population-based survey data of disease prevalence, the geographical distribution of endemic mycoses will continue to be a work in progress.

Footnotes

We declare no competing interests.

Contributor Information

Thuy Le, Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, NC, USA.

Alessandro C Pasqualotto, Department of Medicine, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil; Molecular Biology Laboratory, Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil.

George R Thompson, III, Department of Internal Medicine, Division of Infectious Diseases and the Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento CA 95817, USA.

References

  • 1.Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis 2021; 21: e364–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ning C, Xu B, Thanh NT, et al. The global distribution, drivers, and burden of talaromycosis 1964–2017. Conference of Retrovirus and Opportunistic Infection; March 8–11, 2020 (abstr 749). [Google Scholar]
  • 3.Mahajan VK, Raina RK, Singh S, et al. Case report: histoplasmosis in Himachal Pradesh (India): an emerging endemic focus. Am J Trop Med Hyg 2017; 97: 1749–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections worldwide: thinking outside of the Ohio River valley. Curr Trop Med Rep 2015; 2: 70–80. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES